Gist Healthcare Daily

Recent congressional hearings zero in on healthcare consolidation. Nursing home trade groups sue over the Biden Administration’s new staffing mandate. And a new CDC analysis shows that stroke rates have been on the rise. That’s coming up on today’s episode of Gist Healthcare Daily. 

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily. 

Another human bird flu case linked to dairy cows is reported in Michigan. Drugmakers win a court victory amid the legal battle over the 340-B Drug Pricing Program. And Los Angeles County launches a new plan for tackling medical debt. That’s coming up on today’s episode of Gist Healthcare Daily. 

The Senate Judiciary Committee accuses drugmakers of abusing the patent system, causing prescription drug prices to soar. Patients denied emergency care can now file complaints directly to the Centers for Medicare and Medicaid Services. And a new study reports that many Americans are quitting weight-loss drugs before their health benefits kick in. That’s coming up on today’s episode of Gist Healthcare Daily. 

An Health and Human Services agency announces a new cybersecurity protection program for hospitals. The Senate Finance Committee weighs in on Medicare physician payment reform. And UnitedHealth’s pharmacy benefit manager announces a new drug pricing model. That’s coming up on today’s episode of Gist Healthcare Daily. 

A federal transparency rule on direct-to-consumer prescription drug advertising takes effect. Telehealth company Hims & Hers Health announced it will offer compounded GLP-1 medications. And the Centers for Disease Control and Preventions ends its free COVID vaccine program for the under and uninsured this summer. That’s coming up on today’s episode of Gist Healthcare Daily. 

The U.S. Justice Department starts the formal process to reclassify marijuana as a less dangerous drug. The CDC warns about a possible resurgence of m-pox. And the number of hospital-at-home programs is increasing, even as the future of Medicare reimbursement remains uncertain. That’s coming up on today’s episode of Gist Healthcare Daily. 

The FDA approves self-collection screening for HPV. Eli Lilly reports promising results for its weekly insulin drug. And the country’s only tribal-affiliated medical school graduates its first class of physicians. That’s coming up on today’s episode of Gist Healthcare Daily. 

Jefferson Health and Lehigh Valley Health Network sign an agreement to merge. Preliminary data shows a drop in overdose deaths in 2023. Marking the first decline in years. And Novo Nordisk will test whether its weight-loss drugs can help people with alcohol-related liver disease. That’s coming up on today’s episode of Gist Healthcare Daily.